Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Musculoskeletal
Disease Category: Lower Back Pain
Trial Information
Low Back Pain Not Getting Better?
'A Phase I/II, Multicenter, Placebo-Controlled, Double-Blind, Randomized, Single Administration Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration'
Low Back Pain Not Getting Better?
Your low back pain could actually be the early stages of serious spine problems, specifically degenerative disc disease.
The study doctors at the MGH Center for Pain Medicine are working with the doctors at the MGH Spine Clinic to see if an investigational medication is effective at reducing low back pain caused by problem discs in the lower spine.
If you …
• Are 18 years or older
• Have had low back pain for more than 3 months that is not directly related to previous surgeries
• Are able to have a MRI
• Are able to make several visits to the MGH Spine Clinic
you may qualify to take part in this study.
To learn more about this research study and to see if you qualify, please call or email Naomi Shin, BA at: 617-726-5186 (nshin@partners.org).
Institution: MGH, Massachusetts General Hospital, Boston, MA
Principal Investigator: James P. Rathmell, MD
Enrollment Information
For further information about enrolling a patient in this trial, please contact:
Name: Naomi Shin, BA
Email: nshin@partners.org
Phone: 617-726-5186
Naomi S Shin, CRC
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Phone: 617.726.5186
EMail: nshin@partners.org
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.